Received Sep 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
COVID-19 infection; COVID-19 infection; This is a spontaneous report received from a Consumer or other non HCP. A 71-year-old male patient received BNT162b2 (BNT162B2), in 2020 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "COVID-19 infection". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient's spouse stated that her husband has just been prescribed Paxlovid but patient not able to get it. They wanted more dollars and in the past, patient's had that one, 2 times and there was no payment". After having the Program guidelines explained, stated, she just confused because in the past patient has taken it in 2021 &2023. No, he's being prescribed the same medicine". When offered a transfer to the redacted stated that it might be helpful they both had the Pfizer vaccinations back in 2020. Patient's had the Paxlovid twice and he's gone on to have to have more antibiotics on top of the Paxlovid (inaudible)". There was no confirmation that the Patient currently has Covid. That was implied patient had Covid and Paxlovid previously when the reporter stated, "they both had the Pfizer vaccinations back in 2020. Patient had Paxlovid twice and he's gone on to have to have more antibiotics on top of the Paxlovid". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.